http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0950386-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeae06b0a7192ed20623b56b556c2f28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_438d97f2817a142642c3f0eaf083ede3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0839c53c9802c773f13d215fe57181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99bfab467157549bf8399b840bbf0394
publicationDate 2000-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0950386-A3
titleOfInvention Stent with local rapamycin delivery
abstract Delivery of rapamycin locally, particularly from annintravascular stent, directly from micropores in the stentnbody or mixed or bound to a polymer coating applied onnstent, to inhibit neointimal tissue proliferation andnthereby prevent restenosis. This invention alsonfacilitates the performance of the stent in inhibitingnrestenosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6562065-B1
priorityDate 1998-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0761251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700286-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0938878-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9847447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5728150-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632

Total number of triples: 36.